Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24945,877,1.27 [1.14-1.42],2.3585389334443013e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24971,132,1.57 [1.22-2.04],0.0005611244069645
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26507,148,1.17 [0.89-1.52],0.2601586423804016
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19830,479,1.47 [1.28-1.70],1.0562537867224969e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26446,87,1.09 [0.77-1.54],0.6316940252536779
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25756,76,1.18 [0.81-1.72],0.3879966486792056
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27460,86,1.06 [0.75-1.51],0.7434179566599699
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27480,60,0.87 [0.56-1.34],0.5299913134412524
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25216,46,1.38 [0.89-2.14],0.1550261873383858
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26960,100,1.08 [0.77-1.51],0.6505169222157724
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26926,66,1.22 [0.82-1.81],0.3337360491731348
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27522,65,1.53 [1.06-2.23],0.0240803297337605
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27481,96,1.10 [0.78-1.55],0.5889616719133274
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27472,87,1.12 [0.78-1.60],0.5365190916131881
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Mycoses,27293,43,1.24 [0.78-1.98],0.3663854355999858
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26677,383,1.48 [1.26-1.74],1.1335319987447423e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26438,144,1.62 [1.26-2.08],0.0001559038779534
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26540,246,1.45 [1.19-1.77],0.0002106742223377
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",23901,30,0.58 [0.28-1.18],0.1299248735296819
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",23919,48,1.17 [0.70-1.94],0.5482749470656723
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23997,126,1.35 [1.01-1.80],0.0437862578211443
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24002,131,1.41 [1.07-1.87],0.0153323340426659
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",13438,281,1.02 [0.83-1.26],0.855109221215915
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",10741,27,0.64 [0.31-1.32],0.2268810392095674
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",23920,49,1.84 [1.24-2.72],0.0024500010565462
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,25433,798,1.10 [0.98-1.25],0.1181624975738742
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26475,196,1.03 [0.81-1.31],0.8172506050392412
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27110,77,0.99 [0.68-1.46],0.9777005062074766
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27592,71,1.16 [0.78-1.71],0.4653867257464732
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Rectum,27361,47,1.46 [0.95-2.26],0.0848308884344661
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27600,38,0.87 [0.48-1.57],0.6445361489224457
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Stomach,27639,31,0.80 [0.41-1.57],0.5210951166774358
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm,27334,290,1.27 [1.05-1.54],0.0148587708693692
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27570,113,1.08 [0.79-1.49],0.6255575687582646
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27574,94,1.02 [0.71-1.46],0.933991974019478
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27540,43,0.99 [0.58-1.68],0.956144049320774
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma, any site",27542,43,0.99 [0.58-1.68],0.9565878998498462
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi,27437,242,1.06 [0.84-1.33],0.6174373632191938
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27599,111,1.28 [0.93-1.76],0.1304729007882534
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Other benign neoplasms of skin,27514,186,0.98 [0.76-1.26],0.8695165009012009
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of breast,15256,94,1.11 [0.78-1.57],0.5685899280463536
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Leiomyoma of uterus,14899,680,0.94 [0.81-1.08],0.3505088429117988
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26633,195,1.04 [0.81-1.34],0.7484470319129644
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26530,347,1.16 [0.96-1.39],0.1157009348428079
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26530,347,1.16 [0.96-1.39],0.1157009348428079
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),25326,348,1.35 [1.14-1.60],0.0006358987063483
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27178,79,0.94 [0.63-1.39],0.7528637717564781
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27380,104,1.04 [0.75-1.43],0.832352178085648
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24240,688,1.30 [1.15-1.48],4.1838540115392286e-05
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26342,432,1.22 [1.04-1.44],0.0155677173314547
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25863,114,0.58 [0.41-0.84],0.00411520654948
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26895,54,1.31 [0.88-1.96],0.181088228242099
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25848,99,0.65 [0.44-0.96],0.0302037179264008
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26072,323,0.95 [0.78-1.15],0.5968069544980972
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26063,314,0.95 [0.77-1.15],0.5795720905196171
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25719,178,0.91 [0.68-1.21],0.5126155455627428
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25724,176,0.92 [0.69-1.22],0.5439196051256259
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24079,527,1.23 [1.06-1.42],0.0059476310554555
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",23625,73,1.41 [0.98-2.02],0.0615538328857352
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24035,483,1.23 [1.05-1.43],0.0101636783773956
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,23593,41,1.26 [0.76-2.07],0.3689329058159616
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23630,78,1.58 [1.12-2.23],0.0091823358332758
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Any mental disorder,23976,754,1.41 [1.26-1.58],4.238188135056625e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23512,290,1.49 [1.26-1.77],2.69673466593303e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27202,222,1.12 [0.92-1.35],0.2692781677683677
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27271,158,1.20 [0.96-1.50],0.1000852276035107
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,25673,81,1.34 [0.98-1.84],0.0707244979558164
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27521,81,1.18 [0.86-1.62],0.3122606445305301
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",23303,81,1.36 [0.99-1.86],0.0593222117867782
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Alcohol dependence,25687,95,1.46 [1.11-1.92],0.0068640403995997
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Smoking dependency,25653,66,2.04 [1.50-2.78],6.494614514498436e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23293,71,1.48 [1.06-2.07],0.0225816627511024
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23605,383,1.51 [1.29-1.77],2.2979338649368494e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Depression,25932,332,1.47 [1.25-1.73],4.6382852160915125e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Depression or dysthymia,23455,289,1.55 [1.30-1.85],1.3924304032866892e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",23366,144,0.98 [0.73-1.31],0.8935686131384699
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Other anxiety disorders,26152,69,0.90 [0.60-1.35],0.6051146775091291
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Neurological diseases,24594,1430,1.12 [1.02-1.23],0.0152088505372922
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22925,157,1.20 [0.92-1.56],0.1850266436885422
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27437,127,1.16 [0.87-1.56],0.3156540916668313
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26314,489,1.13 [0.97-1.32],0.1105411278568947
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Epilepsy,25992,167,1.17 [0.91-1.50],0.213447428856447
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Migraine,25928,103,1.23 [0.88-1.72],0.2259806232795
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27269,94,1.26 [0.89-1.78],0.1976290574800316
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27155,39,0.86 [0.48-1.55],0.623893609848851
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other sleep disorders,25996,171,1.14 [0.88-1.48],0.3095005018098689
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Sleep apnoea,27037,133,1.15 [0.86-1.54],0.3454036663434102
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26533,610,1.07 [0.93-1.23],0.3578314698756718
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26058,135,0.98 [0.73-1.32],0.8776455654291221
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26252,329,0.91 [0.75-1.11],0.3727327404682111
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27424,84,1.24 [0.87-1.78],0.2313679827496745
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Hemiplegia,27393,53,1.22 [0.78-1.93],0.3814031675530756
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other neurological diseases,27211,121,1.09 [0.81-1.47],0.5704067798737473
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27176,312,1.02 [0.84-1.25],0.8290093769299703
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27033,169,1.01 [0.77-1.32],0.9624161452084476
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26951,87,1.03 [0.71-1.51],0.8651120708319808
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26967,103,0.89 [0.62-1.27],0.5212264061912033
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26915,51,1.03 [0.62-1.70],0.9138662708229296
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25954,66,0.92 [0.61-1.40],0.7052550069578185
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26073,185,1.06 [0.83-1.37],0.640474736473173
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27031,129,0.79 [0.57-1.09],0.1438681750926662
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27388,25,0.71 [0.34-1.49],0.3635139387860628
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1716,25,0.70 [0.34-1.43],0.3305493907227207
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25697,25,0.71 [0.33-1.50],0.3640197856064872
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27265,49,1.06 [0.66-1.71],0.8108227196544188
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27245,29,1.35 [0.74-2.45],0.3242752131802811
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27178,93,0.86 [0.59-1.27],0.4545296499484647
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27219,96,0.98 [0.69-1.40],0.931133671594016
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27516,122,1.22 [0.91-1.62],0.1833417985756721
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27123,92,0.87 [0.60-1.25],0.4418165468937887
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21651,1944,1.14 [1.05-1.24],0.0022152313156299
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27316,40,0.98 [0.56-1.70],0.930991476283872
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22689,1296,1.08 [0.97-1.20],0.1491562766625113
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertension,22713,1320,1.08 [0.97-1.19],0.1674126333229175
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21441,48,1.07 [0.65-1.74],0.7940726629682306
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26149,563,1.38 [1.20-1.58],4.065302351377453e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Angina pectoris,25933,347,1.32 [1.11-1.57],0.0015334619258309
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26932,135,1.39 [1.07-1.80],0.0149563207958805
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27053,256,1.46 [1.20-1.76],0.0001132753336316
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27533,56,1.28 [0.85-1.93],0.2363608028758516
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25742,156,1.60 [1.26-2.04],0.0001232030893744
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25994,418,1.34 [1.15-1.57],0.0002212845588463
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27125,79,1.37 [0.95-1.98],0.0885176102547924
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27117,175,1.21 [0.94-1.56],0.1461359478035461
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27107,61,1.25 [0.82-1.89],0.30040459452146
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27108,62,1.24 [0.82-1.88],0.3024387193051252
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21452,59,1.24 [0.80-1.91],0.3307184509670939
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25054,46,0.72 [0.41-1.24],0.2321260761947148
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Conduction disorders,25080,72,1.23 [0.82-1.83],0.3171007393761329
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,18894,91,1.33 [0.93-1.89],0.1130951037794276
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,18991,188,0.98 [0.75-1.27],0.8534274427960424
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,25048,40,1.75 [1.09-2.82],0.0216990548225697
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25069,61,1.21 [0.78-1.87],0.3900247405789782
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27144,119,1.20 [0.90-1.62],0.2178345781927977
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27108,112,0.82 [0.59-1.15],0.2602923190465521
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27140,83,0.76 [0.51-1.13],0.1696149071422561
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27188,72,0.73 [0.47-1.12],0.1525418330052282
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26917,50,1.36 [0.90-2.07],0.1480308358115682
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26950,83,1.51 [1.10-2.07],0.0118273709779997
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26417,115,1.12 [0.81-1.54],0.489853827038343
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26397,95,1.17 [0.83-1.64],0.3814369055639648
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27472,91,1.21 [0.85-1.72],0.2930730935161895
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Varicose veins,26732,430,0.99 [0.84-1.18],0.9463939517113492
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypotension,26909,55,0.88 [0.55-1.41],0.595415647739244
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,23406,1902,1.26 [1.17-1.37],9.301949013885748e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27414,135,1.28 [0.97-1.69],0.0793600237934023
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26459,184,1.63 [1.31-2.02],1.2347393377187057e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26433,158,1.77 [1.41-2.23],8.170427045432864e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27044,207,1.54 [1.26-1.89],3.010139872167749e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27042,205,1.55 [1.26-1.90],3.1101115444834125e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26763,652,1.05 [0.92-1.21],0.4460702368571971
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26203,92,1.06 [0.74-1.52],0.7563377567978938
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Nasal polyp,26219,108,0.66 [0.46-0.95],0.0247652633886719
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26528,417,1.10 [0.93-1.30],0.2594473620309701
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26332,221,1.15 [0.92-1.44],0.2273481091349216
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,15928,50,1.35 [0.86-2.13],0.194274931843085
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25311,856,1.16 [1.04-1.30],0.0108555981118219
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Early onset COPD,26931,104,1.31 [0.99-1.74],0.0572092743473097
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26931,104,1.31 [0.99-1.74],0.0572092743473097
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26931,104,1.31 [0.99-1.74],0.0572092743473097
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25911,779,1.09 [0.97-1.23],0.1559985433508217
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Asthma,21172,779,1.24 [1.09-1.40],0.0010067156118395
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21033,779,1.24 [1.09-1.41],0.0008804836150765
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21157,764,1.25 [1.10-1.42],0.0004891914817326
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27454,55,3.48 [2.62-4.62],5.579968497405224e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,26334,42,3.96 [2.91-5.38],1.8865811654846146e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27514,42,3.92 [2.89-5.32],2.026967865132e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26327,35,3.52 [2.45-5.06],8.964238416804704e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural effusion,26322,75,1.40 [0.97-2.02],0.0731849190440603
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,26424,177,1.56 [1.24-1.95],0.0001394053464747
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26809,83,1.40 [1.00-1.97],0.0517667669680625
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19573,5063,1.03 [0.98-1.10],0.2499816261348596
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27046,491,1.04 [0.89-1.22],0.5856783087504192
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27569,141,1.01 [0.75-1.36],0.9452452649328292
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Impacted teeth,27575,132,1.00 [0.73-1.36],0.9761876211884508
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Dental caries,26676,121,1.05 [0.78-1.42],0.7447520766082342
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26661,106,0.82 [0.58-1.15],0.2457673470996914
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27555,156,1.00 [0.75-1.32],0.9730003880945304
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26648,93,1.00 [0.70-1.42],0.9822181378910542
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26397,65,0.89 [0.58-1.36],0.5803938272654349
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27517,45,1.07 [0.65-1.75],0.792969571630244
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22233,198,1.21 [0.97-1.52],0.093443101556046
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23753,1718,1.12 [1.03-1.22],0.0082453074883401
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophagitis,22300,265,1.04 [0.85-1.28],0.7018667019600746
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,22582,547,1.17 [1.01-1.35],0.0312917144450547
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22101,66,0.98 [0.66-1.47],0.9257702389960732
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22164,129,1.19 [0.89-1.59],0.2342924866790339
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22067,32,0.84 [0.45-1.56],0.5734475815048152
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastric ulcer,22136,101,1.05 [0.75-1.46],0.7801287973865411
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,22134,99,1.32 [0.97-1.78],0.0756683571319303
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27535,70,1.03 [0.70-1.51],0.8821111846497891
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Chronic gastritis,22136,101,1.19 [0.87-1.64],0.2657439522957695
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22665,630,1.13 [0.99-1.29],0.0745467355880407
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of appendix,27448,159,0.96 [0.73-1.26],0.7646685963792843
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,22415,380,1.06 [0.89-1.28],0.5037757944471504
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22151,116,1.01 [0.73-1.40],0.9512483474284724
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27441,184,1.14 [0.89-1.45],0.3058269541495551
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute appendicitis,27413,124,0.99 [0.73-1.35],0.9525656828572564
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Hernia,24914,1155,0.93 [0.83-1.03],0.1493617679029097
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Inguinal hernia,24147,388,0.84 [0.70-1.00],0.0545398150887461
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Umbilical hernia,23877,118,0.62 [0.44-0.88],0.0071261652783317
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ventral hernia,23854,95,0.73 [0.50-1.05],0.0879601927366795
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24345,586,1.14 [0.99-1.31],0.0746522417034424
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26766,741,1.05 [0.93-1.19],0.4256595773304987
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,22752,1641,1.09 [1.00-1.19],0.056264857667136
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27305,70,1.07 [0.73-1.57],0.7233213673005355
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27553,100,0.92 [0.65-1.28],0.6081546023201548
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn disease,26125,100,0.92 [0.65-1.29],0.6241215124154972
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26101,76,0.83 [0.56-1.24],0.3637874848314952
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27505,133,0.74 [0.54-1.02],0.0664037569911543
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,26158,133,0.74 [0.54-1.03],0.0710832530257417
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26140,115,0.68 [0.48-0.97],0.0331920562301394
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26614,589,1.14 [0.99-1.30],0.0667942063670417
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26609,584,1.14 [1.00-1.31],0.0539890451874047
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21181,70,1.01 [0.67-1.52],0.9775005043828688
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal stricture,27303,70,0.99 [0.66-1.49],0.96148057904317
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21159,48,1.05 [0.64-1.71],0.8467395323090003
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,21407,296,1.08 [0.89-1.32],0.4326537522673123
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21285,174,1.42 [1.12-1.80],0.0035985581130869
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21358,247,1.17 [0.95-1.45],0.1432797262009328
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Constipation,26478,221,1.15 [0.92-1.45],0.2138033863409779
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27226,83,1.62 [1.16-2.26],0.004282229312631
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21285,174,1.13 [0.88-1.46],0.3511486404184033
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21196,85,0.99 [0.69-1.41],0.9612119306157552
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,21886,775,1.08 [0.95-1.22],0.2210654480255754
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,21289,178,1.13 [0.88-1.45],0.350005856097615
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27214,71,1.62 [1.13-2.33],0.0094121767293308
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of liver,26904,118,1.22 [0.92-1.63],0.1698049338775514
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of liver,26851,65,1.00 [0.66-1.51],0.9871342462820084
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26417,513,1.08 [0.92-1.25],0.3426137832398122
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholelithiasis,26310,406,1.04 [0.88-1.24],0.6321432979540023
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholecystitis,25981,77,1.10 [0.74-1.63],0.6236447974194479
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25947,43,1.08 [0.63-1.82],0.7852502545296658
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,25963,59,0.96 [0.62-1.48],0.8396767647637811
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27474,59,0.95 [0.62-1.47],0.8340812528293208
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26395,275,1.28 [1.06-1.55],0.009454926616019
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26185,65,1.46 [1.00-2.14],0.0473395576896349
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Coeliac disease,26171,51,1.76 [1.19-2.61],0.0046776404230152
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26161,41,1.02 [0.60-1.74],0.9451164659394188
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26296,176,1.27 [1.01-1.60],0.0427248833711991
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,GI-bleeding,26291,171,1.26 [1.00-1.60],0.0514700643230277
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25067,1469,1.07 [0.98-1.18],0.1201897479244778
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27258,99,0.91 [0.65-1.29],0.6114756626552487
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27206,461,0.97 [0.82-1.13],0.6653108676095041
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26542,528,1.19 [1.03-1.37],0.020026715686906
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26864,388,1.13 [0.96-1.34],0.1492458439467376
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26580,104,1.22 [0.90-1.65],0.2072697337282574
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26695,219,1.16 [0.92-1.45],0.2101383124624009
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27383,85,0.89 [0.61-1.30],0.5332432351177829
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27369,71,0.83 [0.54-1.26],0.3817601069847622
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27348,50,0.95 [0.58-1.55],0.8389026146653843
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27467,33,0.53 [0.26-1.05],0.0691987572293239
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27464,30,0.49 [0.24-1.02],0.0579858166356072
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26807,62,0.98 [0.64-1.51],0.922995514972293
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27097,352,0.96 [0.80-1.15],0.6649906799469687
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26083,69,1.41 [0.96-2.06],0.0772153682336425
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26111,97,0.82 [0.57-1.18],0.2810410827363251
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26096,82,0.83 [0.56-1.23],0.3540263303549512
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26223,209,1.26 [1.01-1.57],0.0449928761777253
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26194,180,1.28 [1.01-1.62],0.0417639831276769
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21400,3454,1.18 [1.10-1.25],7.216626021650528e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22990,1825,1.14 [1.05-1.24],0.0019471242110941
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25234,1093,1.21 [1.09-1.34],0.0003651998845592
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21282,117,1.18 [0.87-1.60],0.2865615363385834
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21500,335,1.10 [0.91-1.32],0.3184913264694635
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27304,111,1.18 [0.87-1.61],0.2957559000300714
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27320,99,1.24 [0.90-1.71],0.1867320458416752
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21808,643,1.09 [0.95-1.26],0.1977447587365016
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",24356,643,1.07 [0.94-1.23],0.3070799755243675
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21208,43,0.93 [0.54-1.60],0.8019473582499245
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27253,42,0.93 [0.54-1.61],0.7952717645739871
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,21315,150,1.19 [0.91-1.57],0.2042013626293027
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21189,24,1.24 [0.63-2.41],0.5343557420959886
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,21288,123,1.17 [0.86-1.58],0.3123272304683007
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27526,60,1.10 [0.71-1.70],0.6767344440933406
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,21487,322,1.07 [0.88-1.30],0.5223001065027616
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21382,217,1.04 [0.82-1.30],0.7538704590049072
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,22378,1213,1.15 [1.04-1.27],0.0056222831295751
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21200,35,1.07 [0.59-1.94],0.8278114392583413
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21333,168,1.29 [1.00-1.67],0.0494583749872512
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21200,35,0.77 [0.42-1.43],0.4132987430853168
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21192,27,0.75 [0.36-1.54],0.4297060041951073
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,21681,516,1.00 [0.86-1.17],0.9821530747234304
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,21593,428,0.95 [0.80-1.13],0.5746012238437401
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21884,277,1.43 [1.18-1.73],0.0002421133784183
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27251,151,1.38 [1.06-1.78],0.0154538318298136
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27139,39,2.07 [1.36-3.17],0.0007627763884105
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24720,49,1.63 [1.07-2.48],0.0236920270882775
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24885,214,1.22 [0.98-1.53],0.0799202296625313
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,25555,884,1.26 [1.13-1.41],3.116560981977521e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24805,134,1.30 [0.98-1.72],0.0717526040262379
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24726,55,1.17 [0.76-1.81],0.4776150569505988
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25415,744,1.28 [1.14-1.45],4.363263867571223e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24729,58,1.57 [1.06-2.34],0.0243595059598385
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24914,243,0.99 [0.79-1.23],0.9066705615612876
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24780,109,0.99 [0.71-1.37],0.9362995141404378
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24738,67,1.63 [1.12-2.37],0.0101224764624598
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24817,146,1.44 [1.12-1.87],0.0049960559735742
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24735,64,1.24 [0.83-1.86],0.2925749634957152
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24988,317,1.44 [1.21-1.71],4.250584027597883e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24427,286,1.18 [0.97-1.44],0.0942209218606668
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24195,54,1.30 [0.84-2.00],0.2371302357821074
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24195,54,1.07 [0.67-1.71],0.7632703987132915
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24257,116,1.08 [0.78-1.48],0.6452124025027781
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24197,56,1.14 [0.73-1.76],0.5736413892129644
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24203,62,0.87 [0.55-1.36],0.5419083532772974
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24189,48,0.89 [0.54-1.47],0.6420121766393334
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24365,224,1.31 [1.05-1.63],0.0165707587918023
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24192,51,1.14 [0.71-1.82],0.5961536429255828
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24196,55,1.44 [0.95-2.18],0.0874670419855388
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24249,108,1.47 [1.08-1.99],0.0136016614127784
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24213,72,0.83 [0.55-1.27],0.3944882172497763
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24564,423,1.24 [1.06-1.46],0.0076624298112033
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24285,144,1.17 [0.89-1.55],0.2589147054409699
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24357,216,1.35 [1.09-1.67],0.006699742457118
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26274,97,1.17 [0.84-1.62],0.3436092803303409
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,26512,335,1.25 [1.05-1.49],0.0137212610456589
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26232,55,1.28 [0.84-1.94],0.2479800090859802
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26246,69,0.94 [0.61-1.46],0.7951127791304397
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26292,115,1.20 [0.88-1.64],0.2516357656153777
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23345,4326,1.10 [1.04-1.17],0.0012038874355752
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11187,407,0.98 [0.82-1.17],0.8305633258852285
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,26131,207,1.24 [0.99-1.55],0.0636548808741378
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25978,54,1.08 [0.69-1.69],0.7411454288868686
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26279,43,1.82 [1.19-2.78],0.0055589333796248
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26284,48,1.44 [0.93-2.24],0.1015033468237604
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26290,54,1.08 [0.68-1.71],0.7538196411972151
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27260,232,1.23 [0.99-1.53],0.0585880542875438
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27334,51,1.07 [0.68-1.70],0.7566434992118961
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27190,162,1.36 [1.06-1.75],0.0160928965125934
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27119,91,1.21 [0.86-1.71],0.2724723999107551
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26127,863,1.17 [1.04-1.32],0.0072670938518123
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Cystitis,25342,78,1.10 [0.75-1.61],0.638228403031259
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25331,67,1.13 [0.75-1.70],0.573436993787305
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,25440,176,1.07 [0.83-1.38],0.5843630536596336
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25350,86,1.02 [0.70-1.49],0.9054063716167592
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25871,607,1.20 [1.05-1.37],0.0095234898413783
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10849,69,0.78 [0.50-1.22],0.2782483609921556
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),10816,36,0.84 [0.45-1.57],0.5786867327309702
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,10818,38,1.38 [0.82-2.32],0.2275995752973475
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",10873,93,0.91 [0.63-1.32],0.6272223511550686
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,10847,67,1.11 [0.73-1.68],0.6180052185628042
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,10881,101,1.07 [0.76-1.49],0.7084668837579227
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15108,246,1.07 [0.86-1.33],0.5692349907086315
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,14933,71,1.08 [0.72-1.62],0.6929690005750404
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,14951,89,1.12 [0.78-1.62],0.537078857679933
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,14915,53,1.13 [0.70-1.82],0.6170028492613926
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15076,381,1.38 [1.17-1.63],0.0001632497916134
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,14776,81,1.30 [0.89-1.89],0.1773743358754648
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,14883,188,1.63 [1.31-2.03],1.4517162511423098e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,13893,2735,1.00 [0.93-1.08],0.9596991874680518
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,11454,296,1.22 [1.00-1.48],0.048002711575297
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,11249,91,1.23 [0.88-1.73],0.2284952926018519
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11271,113,1.46 [1.08-1.96],0.0131248479136831
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11459,301,1.03 [0.84-1.26],0.7881220936337064
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11461,303,0.95 [0.77-1.17],0.645961557648655
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11624,466,1.04 [0.88-1.23],0.6516084579657375
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11320,162,0.98 [0.74-1.30],0.9029739889023534
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11375,217,1.00 [0.78-1.27],0.9747632008701098
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,11236,78,0.84 [0.55-1.28],0.4075103150234168
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,11296,138,1.33 [1.01-1.75],0.0390947044348247
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",15261,198,1.26 [1.00-1.59],0.0482985662619743
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,15269,189,1.26 [1.00-1.60],0.0520106857211732
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,15288,109,1.13 [0.81-1.57],0.4654607837659485
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",15281,119,1.14 [0.84-1.55],0.4052167619731806
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11230,72,1.49 [1.04-2.14],0.0313668876960889
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11220,62,0.97 [0.62-1.51],0.8777536581125641
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11233,75,1.10 [0.75-1.61],0.613146792181015
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,15185,374,1.13 [0.95-1.35],0.1678267988220335
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",12285,1127,1.01 [0.90-1.13],0.8769964378779117
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11929,771,1.03 [0.90-1.17],0.6551900826630548
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",15268,155,1.32 [1.01-1.71],0.0394270363764193
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11507,349,1.02 [0.84-1.23],0.8764358231848002
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11436,278,1.05 [0.85-1.30],0.6324899269239543
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11419,261,0.97 [0.77-1.22],0.8100148403618711
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Female infertility,11273,115,1.08 [0.77-1.52],0.6398924038806879
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",11266,108,1.01 [0.71-1.44],0.9640090180535176
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,15281,863,0.83 [0.73-0.96],0.008913920158699
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,15287,1171,0.76 [0.67-0.86],1.7739881969532008e-05
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,15283,462,0.92 [0.77-1.09],0.3121842998523975
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,14952,131,0.79 [0.57-1.09],0.1479076135427829
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,15009,188,0.98 [0.75-1.27],0.8780092808689116
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,14976,155,0.89 [0.68-1.17],0.4136863767569979
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",15301,164,0.78 [0.58-1.06],0.1148317340312484
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,15303,161,0.83 [0.61-1.12],0.2192224396642925
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,15298,405,0.86 [0.71-1.04],0.1112786724570025
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,15011,118,0.98 [0.71-1.36],0.902922899697672
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,15120,227,0.91 [0.72-1.16],0.4683723646854937
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,14563,145,0.99 [0.73-1.34],0.9418625411341972
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,14614,196,0.79 [0.60-1.04],0.0873010551957655
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,14666,248,0.85 [0.67-1.08],0.1869293289747148
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,14562,144,0.86 [0.63-1.18],0.3460678877264734
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,14553,135,1.00 [0.74-1.36],0.9840673287387672
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,14567,149,0.63 [0.46-0.87],0.0046936219106557
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,14343,227,0.74 [0.57-0.96],0.0238313713068384
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],14539,423,0.75 [0.62-0.91],0.0034429549515649
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,14766,650,0.79 [0.67-0.93],0.003712340853918
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",15304,165,0.74 [0.54-0.99],0.0458748602129722
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,13876,126,0.69 [0.49-0.97],0.0336167765137729
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",14215,99,0.88 [0.60-1.29],0.5083348434522548
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,15311,332,0.80 [0.65-0.99],0.0400569655770214
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,15230,251,0.79 [0.62-1.00],0.0548906684476923
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",15298,247,0.94 [0.74-1.19],0.5926966538198617
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",15289,238,0.94 [0.74-1.19],0.6031389608197
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27392,34,0.81 [0.44-1.51],0.5135028891416977
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26004,513,1.12 [0.96-1.29],0.1468748631133853
